Manufacturer of packaging components and delivery systems for injectable drugs and healthcare products, West Pharmaceuticals, has announced it will present on best practices for improving patient outcomes through integrated containment and delivery systems at the 6th Annual InnoPack Pharma Confex in Mumbai, India.
Biologics trends
The presentation, which will be made today (1 June), will conclude a week-long series of educational seminars and activities in India focused on trends and best practices in biologic drug delivery.
“Biosimilars are one of the fast-growing segments in India and fill an important need for advanced and affordable targeted therapies. These sophisticated, and often sensitive molecules, also present unique challenges in drug containment and delivery,” said Troy Player, vice president and managing director, Asia Pacific, West Pharmaceutical Services.
West’s presentation will be made by Graham Reynolds, vice president and general manager, Global Biologics. It will be titled ‘Trends in Containment and Delivery of Biologics’ and will discuss the trends in biologic drug delivery (including biosimilars), key factors to consider in the selection of a containment and delivery system and best practices for improving patient outcomes through integrated containment and delivery solutions.
Further, the company will showcase several drug delivery systems and packaging components at the event, including SmartDose platform, SelfDose patient-controlled injector, NovaPure components and Daikyo Crystal Zenith cyclic olefin polymer.